Breaking News
Subscribe Now 0
🧐 ProPicks AI October update is out now! See which stocks made the list Pick Stocks with AI

Search Results for "biomarin":

Results: 432

Quotes

BMRN Biomarin Pharmaceutical Inc Stock - NASDAQ equities AKBM Aker Biomarine AS Stock - Oslo equities B1MR34 Biomarin Pharmaceutical Inc Stock - B3 equities BMRN Biomarin Pharmaceutical Inc Stock - Vienna equities AKBMNOK Aker Biomarine AS Stock - Stockholm equities 1BMRN Biomarin Pharmaceutical Inc Stock - Milan equities BMRN Biomarin Pharmaceutical Inc Stock - TradeGate equities
Show all (7)

News

BridgeBio's SWOT analysis: genetic disease innovator's stock faces market challenges
By Investing.com

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with genetic diseases and cancers. The company has...

Wall Street SWOT: BioMarin stock poised for growth amid rare disease focus
By Investing.com

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is positioning itself as a leader in the rare disease treatment market, with a focus on innovative biopharmaceuticals driven by genetic causes. The company's...

Wall Street SWOT: Ascendis Pharma stock faces pivotal moment with key drug data
By Investing.com

Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company focused on developing innovative therapies, stands at a critical juncture as it awaits crucial clinical data and regulatory decisions....

Show all (162)

Analysis

BioMarin Begins Pediatric Study On Achondroplasia Candidate
By Zacks Investment Research

BioMarin Pharmaceutical Inc (NASDAQ:CRSP) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks hereCRISPR Therapeutics’ loss per share...

BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 7.5%
By Zacks Investment Research

BioMarin Pharmaceutical Inc. (NASDAQ:EBS) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Is BMRN going up? Or down? Predict to see...

Biotech Stock To Watch: Sarepta, Biomarin, Acadia
By Joshua Rodriguez

Sarepta Therapeutics On Monday April 25, 2016 Sarepta Therapeutics (NASDAQ:SRPT) had a FDA advisory panel shoot down its drug Eteplirsen, used to treat patients with Duchenne Muscular Dystrophy --...

Show all (263)
Results: 7

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 162

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 263

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Apple
Continue with Google
or
Sign up with Email